Trials / Completed
CompletedNCT02823457
VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C
Evaluating Values-based Motivational Interviewing to Increase Treatment Completion With Fixed Dose Combination MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders and Treatment-naïve Genotype 1 Chronic Hepatitis C
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- G.V. (Sonny) Montgomery VA Medical Center · Federal
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study implement a values-based motivational interviewing (VBMI) intervention to promote treatment completion with fixed dose combination (FDC) MK-5172/MK-8742 x 12 weeks among 30 Veterans with substance use disorder (SUD) and treatment naïve genotype 1 chronic hepatitis C virus (HCV) infection.
Detailed description
The investigators will conduct a prospective study of 30 Veterans with treatment-naive genotype 1 chronic hepatitis C infection admitted to the Substance Abuse Residential Rehabilitation Treatment Program (SARRTP) at the G.V. (Sonny) Montgomery VA Medical Center. Enrolled veterans will be treated MK-5172/MI-8742 while receiving a 12 week values based motivational intervention to promote completion of HCV treatment. MK-5172/MK-8742 will be prescribed in accordance with the package insert.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | VBMI | 12 week values based motivational interviewing intervention with a licensed psychologist |
Timeline
- Start date
- 2017-04-05
- Primary completion
- 2020-01-30
- Completion
- 2020-01-30
- First posted
- 2016-07-06
- Last updated
- 2022-01-18
- Results posted
- 2021-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02823457. Inclusion in this directory is not an endorsement.